Global Molecular Diagnostics Market Report By Technology (In-Situ Hybridization, Chips And Microarrays, Mass Spectrometry, DNA Sequencing, Polymerase Chain Reaction (PCR)-Based Methods , And Other Technologies), Application (Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing, And Blood Screening), Product (Instruments, Reagents, And Other Products), End User (Hospitals, Laboratories, And Other End Users) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2028

Name: Global Molecular Diagnostics Market Report
Brand: Value Market Research
SKU: Medical Devices
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11210463

April 2021

As per this study the Global Molecular Diagnostics Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.

Molecular diagnostics describes a class of diagnostic tests that assess a person’s health specifically at a molecular level, detecting and measuring specific genetic sequences in DNA or RNA or the proteins they express. Molecular diagnostics identify the gene, RNA, and protein variations that specifies whether a specific person is predisposed to have a disease, whether they actually have a disease or whether a specific treatment option is likely to be effective for a specific disease. Molecular diagnostics tests can also detect and quantify the presence of specific viruses, bacteria, or types of cells.

Market Dynamics

The rising prevalence of infectious diseases such as tuberculosis, hepatitis and various types of cancer are the major factors boosting the market growth of molecular diagnostics. Moreover, rising government initiatives in order to standardize biopharmaceutical and health sector are also expected to expand the market growth over the forecast period. However, the high cost of diagnosis and lack of experienced professionals are some factors restraining market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of molecular diagnostics.

Market Segmentation

The broad molecular diagnostics market has been sub-grouped into technology, application, product, and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Technology

In-Situ Hybridization
Chips and Microarrays
Mass Spectrometry
DNA Sequencing
Polymerase Chain Reaction (PCR)-Based Methods
Other Technologies

By Application

By Product

Instruments
Reagents
Other Products

By End User

Hospitals
Laboratories
Other End Users

Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for molecular diagnostics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Global Molecular Diagnostics Market Share by Region (Representative Graph)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the molecular diagnostics market include Abbott Laboratories, Agilent Technologies/Dako, Becton, Dickinson and Company, Cepheid Inc., Genomic Health Inc., Hologic Corporation, Illumina Inc., Myriad Genetics, Qiagen, Roche Diagnostics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Molecular Diagnostics Market
       2.2. Global Molecular Diagnostics Market Snapshot

3 . MOLECULAR DIAGNOSTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Molecular Diagnostics Market
       3.3. Market Restraints of Molecular Diagnostics Market
       3.4. Opportunities of Molecular Diagnostics Market
       3.5. Trends of Molecular Diagnostics Market
       3.6. Porter’s Five Force Analysis of Molecular Diagnostics Market
       3.7. Molecular Diagnostics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Product
           3.7.4 Market Attractive Analysis by End User
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Molecular Diagnostics Value Chain Analysis
       4.2. Molecular Diagnostics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Molecular Diagnostics Raw Material Manufactures List
           4.2.3. Price Trend of Molecular Diagnostics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
       5.1 Overview by Technology
       5.2 Global Molecular Diagnostics Market Analysis by Technology
       5.3 Market Analysis of In-Situ Hybridization by Regions
       5.4 Market Analysis of Chips and Microarrays by Regions
       5.5 Market Analysis of Mass Spectrometry by Regions
       5.6 Market Analysis of DNA Sequencing by Regions
       5.7 Market Analysis of Polymerase Chain Reaction (PCR)-Based Methods by Regions
       5.8 Market Analysis of Other Technologies by Regions

6 . GLOBAL MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Molecular Diagnostics Market Analysis by Application
       6.3 Market Analysis of Infectious Disease by Regions
       6.4 Market Analysis of Oncology by Regions
       6.5 Market Analysis of Pharmacogenomics by Regions
       6.6 Market Analysis of Microbiology by Regions
       6.7 Market Analysis of Genetic Disease Screening by Regions
       6.8 Market Analysis of Human Leukocyte Antigen Typing by Regions
       6.9 Market Analysis of Blood Screening by Regions

7 . GLOBAL MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT
       7.1 Overview by Product
       7.2 Global Molecular Diagnostics Market Analysis by Product
       7.3 Market Analysis of Instruments by Regions
       7.4 Market Analysis of Reagents by Regions
       7.5 Market Analysis of Other Products by Regions

8 . GLOBAL MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Global Molecular Diagnostics Market Analysis by End User
       8.3 Market Analysis of Hospitals by Regions
       8.4 Market Analysis of Laboratories by Regions
       8.5 Market Analysis of Other End Users by Regions

9 . GLOBAL MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Molecular Diagnostics Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Molecular Diagnostics Market Estimate by Market Segment
           9.4.3. Europe Molecular Diagnostics Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Molecular Diagnostics Market Estimate by Market Segment
           9.5.3. Asia Pacific Molecular Diagnostics Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Molecular Diagnostics Market Estimate by Market Segment
           9.6.3. Latin America Molecular Diagnostics Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Molecular Diagnostics Market Estimate by Market Segment
           9.7.3. Middle East & Africa Molecular Diagnostics Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa

10 COMPETITIVE LANDSCAPE OF THE MOLECULAR DIAGNOSTICS COMPANIES
       10.1. Molecular Diagnostics Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 COMPANY PROFILES OF MOLECULAR DIAGNOSTICS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Abbott Laboratories
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Agilent Technologies/Dako
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Becton, Dickinson and Company
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Cepheid Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Genomic Health Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Hologic Corporation
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Illumina Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Myriad Genetics
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Qiagen
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Roche Diagnostics
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments

12. IMPACT ANALYSIS OF COVID-19 OUTBREAK
12.1. Impact Analysis of Covid-19 Outbreak on the Market
12.1.1. Direct Impact on Production
12.1.2. Supply Chain and Market Disruption
12.1.3. Financial Impact on Firms and Financial Markets
12.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
12.3. Pre V/S Post COVID-19 Market
12.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
12.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210463

April 2021

Report Formats: